Skip to main content

Table 2 Review of all reported cases of hypothalamic hamartomas visualized through cranial ultrasound

From: Neuroimaging appearance of hypothalamic hamartomas in monozygotic twins with Pallister-Hall syndrome: case report and review of the literature

Author (year)

GA at birth (weeks)

Age at diagnosis

Neuroimaging

Histological confirmation

PHS Diagnosis

Prenatal Examination

Postnatal Examination

CUS

MRI

Location

Size

(cm)

Echogenicity

Hydrocephalus

Mass effect

Size (cm)

Signal

MRS

Martijn

(1984)

[19]

n.a.

4 months

n.a.

n.a.

2

Hyperechoic

yes

yes

n.a.

n.a.

n.a.

n.a.

no

Guibaud et al. (1995)

[20]

Term

14 days

n.a.

Midline, anterior to the posterior fossa

4.6 × 3.3

Hyperechoic

no

yes

5

T1: isontense,

T2: eterogeneously hyperintense. Nonenhancing

n.a.

yes, examination of surgical specimen

no

Kos et al.

(2008)

[21]

36

n.a.

n.a.

Hypothalamus

2.5

Isoechoic

no

n.a.

n.a.

Isointense on all sequences. Nonenhancing.

n.a.

n.a.

yes, GLI3 mutation (Q717X)

Joo Yeon Lee et al.

(2016)

[22]

36

n.a.

28 weeks GA: arachnoid cyst

Anterior to the left temporal lobe

5.1 × 3.5

Isoechoic

no

yes

6 × 3 × 4.3

Isointense on all sequences. Nonenhancing. Few areas with slightly high T1 signal intensity.

Chemical composition similar to white matter

yes,

surgical biopsy

no

Present Case

34

10 days

Unremarkable

Suprasellar region, anterior to the brainstem

2.1 × 1

Isoechoic

no

Displacement of third ventricle floor

3.2 × 2.8 × 1.6

Isointense

Mild reduction of NAA

no

yes, GLI3 heterozygous mutation

(p.Thr694fs)

  1. Abbreviations: GA Gestational age, CUS Cranial ultrasound, MRI Magnetic resonance imaging, MRS Magnetic resonance spectroscopy, PHS Pallister-Hall syndrome; n.a., data not available; NAA, N-acetylaspartate